# Generated by cath-resolve-hits v0.16.10-0-g99edb28, one of the cath-tools (https://github.com/UCLOrengoGroup/cath-tools)
#FIELDS query-id match-id score boundaries resolved cond-evalue indp-evalue
sp|O43897|TLL1_HUMAN Astacin 242.3 155-348 155-348 1e-75 3.2e-72
sp|O43897|TLL1_HUMAN CUB 116.3 349-458 349-458 2.6e-37 8.3e-34
sp|O43897|TLL1_HUMAN CUB 139.1 462-571 462-571 2.2e-44 7e-41
sp|O43897|TLL1_HUMAN FXa_inhibition 36.3 578-614 578-614 1.7e-12 5.6e-09
sp|O43897|TLL1_HUMAN CUB 123.1 618-727 618-727 2e-39 6.3e-36
sp|O43897|TLL1_HUMAN EGF_CA 20.9 730-774 730-774 1e-07 0.00033
sp|O43897|TLL1_HUMAN CUB 129.1 774-883 775-883 2.7e-41 8.7e-38
sp|O43897|TLL1_HUMAN CUB 100.9 887-1000 887-1000 1.6e-32 5.1e-29
sp|O57460|TLL1_DANRE Astacin 242.5 164-357 164-357 9.8e-76 2.7e-72
sp|O57460|TLL1_DANRE CUB 118.4 358-467 358-467 6.8e-38 1.9e-34
sp|O57460|TLL1_DANRE CUB 139.4 471-580 471-580 2.1e-44 5.8e-41
sp|O57460|TLL1_DANRE FXa_inhibition 40 587-623 587-623 1.4e-13 3.9e-10
sp|O57460|TLL1_DANRE CUB 128 627-736 627-736 7.3e-41 2e-37
sp|O57460|TLL1_DANRE FXa_inhibition 35.7 743-778 743-778 3.1e-12 8.4e-09
sp|O57460|TLL1_DANRE CUB 124.3 783-892 783-892 1.1e-39 2.9e-36
sp|O57460|TLL1_DANRE CUB 104.8 896-1009 896-1009 1.2e-33 3.2e-30
sp|P13497|BMP1_HUMAN Astacin 246.9 128-321 128-321 4.6e-77 1.3e-73
sp|P13497|BMP1_HUMAN CUB 119.4 322-431 322-431 3.3e-38 8.9e-35
sp|P13497|BMP1_HUMAN CUB 141.1 435-544 435-544 6.1e-45 1.7e-41
sp|P13497|BMP1_HUMAN FXa_inhibition 38.9 551-587 551-587 3e-13 8.2e-10
sp|P13497|BMP1_HUMAN CUB 127.1 591-700 591-700 1.3e-40 3.7e-37
sp|P13497|BMP1_HUMAN EGF_CA 23.9 703-743 703-743 1.4e-08 3.9e-05
sp|P13497|BMP1_HUMAN CUB 127.8 747-856 747-856 8.2e-41 2.2e-37
sp|P13497|BMP1_HUMAN CUB 107.8 860-973 860-973 1.3e-34 3.7e-31
sp|P25723|TLD_DROME Astacin 230 144-339 144-339 5.8e-72 1.8e-68
sp|P25723|TLD_DROME CUB 65.5 377-474 377-474 1.7e-21 5.3e-18
sp|P25723|TLD_DROME CUB 131.6 478-588 478-588 4.8e-42 1.5e-38
sp|P25723|TLD_DROME EGF_CA 38.9 591-630 591-630 2.4e-13 7.8e-10
sp|P25723|TLD_DROME CUB 108.4 634-750 634-750 7.4e-35 2.4e-31
sp|P25723|TLD_DROME FXa_inhibition 38.4 757-792 757-792 3.7e-13 1.2e-09
sp|P25723|TLD_DROME CUB 116.3 797-906 797-906 2.8e-37 8.8e-34
sp|P25723|TLD_DROME CUB 109.5 910-1023 910-1023 3.6e-35 1.1e-31
sp|Q20176|NAS39_CAEEL Astacin 236.1 55-248 55-248 7.8e-74 2.5e-70
sp|Q20176|NAS39_CAEEL CUB 97.6 382-496 382-496 1.7e-31 5.4e-28
sp|Q20176|NAS39_CAEEL EGF_CA 31.9 499-538 499-538 3.8e-11 1.2e-07
sp|Q20176|NAS39_CAEEL CUB 89.3 542-645 542-645 6.5e-29 2.1e-25
sp|Q20176|NAS39_CAEEL FXa_inhibition 35.1 652-687 652-687 3.9e-12 1.3e-08
sp|Q20176|NAS39_CAEEL CUB 108.7 692-801 692-801 6.3e-35 2e-31
sp|Q20176|NAS39_CAEEL CUB 91 805-920 805-920 2e-29 6.3e-26
sp|Q9Y6L7|TLL2_HUMAN Astacin 242.9 157-350 157-350 7.5e-76 2e-72
sp|Q9Y6L7|TLL2_HUMAN CUB 112.7 351-460 351-460 4e-36 1.1e-32
sp|Q9Y6L7|TLL2_HUMAN CUB 139.2 464-573 464-573 2.5e-44 6.8e-41
sp|Q9Y6L7|TLL2_HUMAN FXa_inhibition 36.7 580-616 580-616 1.5e-12 4e-09
sp|Q9Y6L7|TLL2_HUMAN CUB 127.8 620-729 620-729 8.3e-41 2.3e-37
sp|Q9Y6L7|TLL2_HUMAN EGF_CA 25.8 732-771 732-771 3.4e-09 9.3e-06
sp|Q9Y6L7|TLL2_HUMAN CUB 118.5 776-885 776-885 6.2e-38 1.7e-34
sp|Q9Y6L7|TLL2_HUMAN CUB 104.7 889-1002 889-1002 1.2e-33 3.4e-30
tr|A0A2R8QEK5|A0A2R8QEK5_DANRE Astacin 244.4 117-310 117-310 2.6e-76 7.2e-73
tr|A0A2R8QEK5|A0A2R8QEK5_DANRE CUB 114.5 311-420 311-420 1.2e-36 3.2e-33
tr|A0A2R8QEK5|A0A2R8QEK5_DANRE CUB 143.9 424-533 424-533 8.4e-46 2.3e-42
tr|A0A2R8QEK5|A0A2R8QEK5_DANRE FXa_inhibition 37.7 540-576 540-576 7e-13 1.9e-09
tr|A0A2R8QEK5|A0A2R8QEK5_DANRE CUB 114.3 580-699 580-699 1.3e-36 3.7e-33
tr|A0A2R8QEK5|A0A2R8QEK5_DANRE EGF_CA 24.5 702-741 702-741 9.1e-09 2.5e-05
tr|A0A2R8QEK5|A0A2R8QEK5_DANRE CUB 122.5 746-855 746-855 3.6e-39 9.8e-36
tr|A0A2R8QEK5|A0A2R8QEK5_DANRE CUB 107.9 859-972 859-972 1.3e-34 3.5e-31
tr|A0A2R8RPM9|A0A2R8RPM9_DANRE Astacin 241.6 111-304 111-304 2.2e-75 5.4e-72
tr|A0A2R8RPM9|A0A2R8RPM9_DANRE CUB 108.6 305-414 305-414 8.7e-35 2.1e-31
tr|A0A2R8RPM9|A0A2R8RPM9_DANRE CUB 139.8 418-527 418-527 1.8e-44 4.2e-41
tr|A0A2R8RPM9|A0A2R8RPM9_DANRE FXa_inhibition 35.1 534-570 534-570 5.5e-12 1.3e-08
tr|A0A2R8RPM9|A0A2R8RPM9_DANRE CUB 119 574-683 574-683 5.1e-38 1.2e-34
tr|A0A2R8RPM9|A0A2R8RPM9_DANRE EGF_CA 27.1 686-726 686-726 1.5e-09 3.7e-06
tr|A0A2R8RPM9|A0A2R8RPM9_DANRE CUB 124.9 730-839 730-839 7.6e-40 1.8e-36
tr|A0A2R8RPM9|A0A2R8RPM9_DANRE CUB 106.7 843-956 843-956 3.4e-34 8.2e-31
tr|F1QPG2|F1QPG2_DANRE Astacin 241.5 111-304 111-304 2.2e-75 5.4e-72
tr|F1QPG2|F1QPG2_DANRE CUB 108.6 305-414 305-414 8.7e-35 2.1e-31
tr|F1QPG2|F1QPG2_DANRE CUB 139.8 418-527 418-527 1.8e-44 4.2e-41
tr|F1QPG2|F1QPG2_DANRE FXa_inhibition 35.1 534-570 534-570 5.5e-12 1.3e-08
tr|F1QPG2|F1QPG2_DANRE CUB 119 575-684 575-684 5.2e-38 1.2e-34
tr|F1QPG2|F1QPG2_DANRE EGF_CA 27.1 687-727 687-727 1.6e-09 3.7e-06
tr|F1QPG2|F1QPG2_DANRE CUB 124.9 731-840 731-840 7.7e-40 1.8e-36
tr|F1QPG2|F1QPG2_DANRE CUB 106.7 844-957 844-957 3.4e-34 8.2e-31
tr|F1REM3|F1REM3_DANRE Astacin 244.4 117-310 117-310 2.6e-76 7.1e-73
tr|F1REM3|F1REM3_DANRE CUB 114.5 311-420 311-420 1.1e-36 3.1e-33
tr|F1REM3|F1REM3_DANRE CUB 143.9 424-533 424-533 8.3e-46 2.3e-42
tr|F1REM3|F1REM3_DANRE FXa_inhibition 37.8 540-576 540-576 6.9e-13 1.9e-09
tr|F1REM3|F1REM3_DANRE CUB 123.9 580-689 580-689 1.4e-39 3.8e-36
tr|F1REM3|F1REM3_DANRE EGF_CA 24.5 692-731 692-731 9e-09 2.5e-05
tr|F1REM3|F1REM3_DANRE CUB 122.6 736-845 736-845 3.5e-39 9.6e-36
tr|F1REM3|F1REM3_DANRE CUB 107.9 849-962 849-962 1.3e-34 3.4e-31
tr|Q9VC47|Q9VC47_DROME Astacin 244.6 527-722 527-722 2e-76 6.5e-73
tr|Q9VC47|Q9VC47_DROME CUB 79 723-836 723-836 1e-25 3.3e-22
tr|Q9VC47|Q9VC47_DROME CUB 124.8 840-951 840-951 6e-40 1.9e-36
tr|Q9VC47|Q9VC47_DROME FXa_inhibition 35.4 958-993 958-993 3.3e-12 1.1e-08
tr|Q9VC47|Q9VC47_DROME CUB 102.6 997-1111 997-1111 4.7e-33 1.5e-29
tr|Q9VC47|Q9VC47_DROME FXa_inhibition 34.2 1118-1153 1118-1153 7.7e-12 2.5e-08
tr|Q9VC47|Q9VC47_DROME CUB 118.4 1158-1267 1158-1267 5.8e-38 1.9e-34
tr|Q9VC47|Q9VC47_DROME CUB 78.9 1271-1388 1271-1388 1.1e-25 3.7e-22
